Icon

VALCHLOR (nda202317)- (EQ 0.016% BASE)

MECHLORETHAMINE HYDROCHLORIDE HELSINN
EQ 0.016% BASE
No Yes
2029-Jul-08 Expired
2020-Aug-23 None
None No
VALCHLOR is an alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 0.016% BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.